STAT

Pfizer spends $11.4 billion to buy Array BioPharma for its cancer drug chemistry

Pfizer said it will spend $11.4 billion in cash to purchase Array BioPharma, a Boulder, Colo.-based biotech known as a top choice among biotechnology firms that need to synthesize new…

Pfizer said Monday morning that it will spend $11.4 billion in cash to purchase Array BioPharma, a Boulder, Colo.-based biotech known not only for developing its own medicines but as being a top choice among biotechnology firms that need to synthesize new drugs. Pfizer said

You're reading a preview, sign up to read more.

More from STAT

STAT6 min readSociety
Health Officials Are Hunting For The Culprit Behind Vaping-related Illnesses. Here Are Five Questions About The Outbreak
What’s causing it? And do all the cases represent the same illness? Those and other big, looming questions about the recent spate of vaping-related illnesses and deaths.
STAT2 min readPolitics
Couple Stole Trade Secrets From U.S. Children’s Hospital To Market Their Chinese Biotech, Prosecutors Say
Prosecutors say a San Diego couple stole trade secrets from a U.S. children’s hospital and then used the information to market their Chinese biotechnology firm.
STAT6 min readSociety
Opinion: Ease Financial Toxicity By Putting Electronic Medical Records To Work
Clicking away on an electronic health record in the digital darkness of my exam room, I epitomize the moral injury of modern medicine as I systematically dispense doses of financial…